HMGB1 and infarction: Elevated serum HMGB1 of is associated with adverse clinical outcomes in patients with myocardial infarction. HMGB1 blockade intramyocardial infarction model aggravated left ventricular remodeling possibly via impairment of the infarct-healing process.